Insights

Strategic Partnerships Leverage Proteus Genomics' existing collaboration with BC Platforms to explore joint offerings in pharmacogenomics, data integration services, and genomic analytics for healthcare providers, expanding scope beyond clinical testing into data-driven decision support.

High-Complexity Expertise Target mid to large clinics and health systems that require advanced RT qRT-PCR, NGS, and custom diagnostic panels. Position Proteus Genomics as a precision diagnostics partner for infectious disease, urinary, wound, respiratory, and women's health testing with rapid, actionable results.

Software Enabled Highlight Pro-Vision software and cloud-enabled reporting as differentiators for streamlined results delivery, enabling value-added services such as remote monitoring, provider dashboards, and integrated EHR/clinical decision support integrations.

Scale Opportunities With 11-50 employees and a revenue range of mid single to upper single digits, pursue pilot programs or regional partnerships with hospitals and independents to demonstrate efficiency gains, cost reductions, and improved patient outcomes to justify broader adoption.

Market Positioning Position as a specialized genomic diagnostics lab focused on real-time testing and pharmacogenomics, offering a compelling value proposition for labs and biotechs seeking niche capabilities, data collaboration, and differentiated test panels to outperform larger, less specialized competitors.

Proteus Genomics Tech Stack

Proteus Genomics uses 8 technology products and services including Gravatar, Cloudflare, WooCommerce, and more. Explore Proteus Genomics's tech stack below.

  • Gravatar
    Audio, Video, Graphics
  • Cloudflare
    Content Management System
  • WooCommerce
    E-commerce
  • Vue.js
    Javascript Frameworks
  • Microsoft Azure
    Platform As A Service
  • Jetpack
    Web Platform Extensions
  • Endurance Page Cache
    Web Platform Extensions
  • Apache HTTP Server
    Web Servers

Proteus Genomics's Email Address Formats

Proteus Genomics uses at least 1 format(s):
Proteus Genomics Email FormatsExamplePercentage
First.Last@plabs.comJohn.Doe@plabs.com
86%
Last@plabs.comDoe@plabs.com
11%
FLast@plabs.comJDoe@plabs.com
3%

Frequently Asked Questions

What is Proteus Genomics's phone number?

Minus sign iconPlus sign icon
You can contact Proteus Genomics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Proteus Genomics's official website and social media links?

Minus sign iconPlus sign icon
Proteus Genomics's official website is plabs.com and has social profiles on LinkedIn.

What is Proteus Genomics's SIC code NAICS code?

Minus sign iconPlus sign icon
Proteus Genomics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Proteus Genomics have currently?

Minus sign iconPlus sign icon
As of July 2026, Proteus Genomics has approximately 20 employees across 1 continents, including North America. Key team members include Chief Sales Officer (cso): T. B.Operations: C. G.Medical Transcription Editor: L. G.. Explore Proteus Genomics's employee directory with LeadIQ.

What industry does Proteus Genomics belong to?

Minus sign iconPlus sign icon
Proteus Genomics operates in the Biotechnology Research industry.

What technology does Proteus Genomics use?

Minus sign iconPlus sign icon
Proteus Genomics's tech stack includes GravatarCloudflareWooCommerceVue.jsMicrosoft AzureJetpackEndurance Page CacheApache HTTP Server.

What is Proteus Genomics's email format?

Minus sign iconPlus sign icon
Proteus Genomics's email format typically follows the pattern of First.Last@plabs.com. Find more Proteus Genomics email formats with LeadIQ.

When was Proteus Genomics founded?

Minus sign iconPlus sign icon
Proteus Genomics was founded in 2015.
Proteus Genomics logo

Proteus Genomics

Biotechnology ResearchAlabama, United States11-50 Employees

Proteus Genomics is a biotechnology research laboratory focused on infectious disease microbiology and molecular diagnostics. Based in Birmingham, Alabama, the company specializes in real-time RT-qPCR and next-generation DNA sequencing, offering custom test panels such as those for urinary tract infections, wound and nail infections, respiratory conditions, COVID, sexually transmitted infections, and women’s health, supported by its Pro-Vision software. Its services are aimed at providing clinicians and health systems with precise, actionable patient data to improve clinical and economic outcomes. The organization operates within the high-complexity CLIA framework and employs a team of clinical reference scientists to develop and deliver targeted diagnostic solutions. In addition to its core testing capabilities, Proteus Genomics has engaged in partnerships to integrate genomic and healthcare data, reflecting its role in advancing genomic-informed diagnostics. The company positions itself in the biotechnology research sector as a specialized laboratory that advances precision-guided, patient-focused outcomes. A notable recent development involves a collaboration with BC Platforms to streamline genomic data integration, underscoring its involvement in data-driven healthcare. } }{

Section iconCompany Overview

Phone number
Website
plabs.com
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
11-50

Section iconFunding & Financials

  • $10M$25M

    Proteus Genomics's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Proteus Genomics's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.